|
| 37978284 | The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. | Nat Med | 2024 |
| 37944912 | Pediatric low-grade glioma: State-of-the-art and ongoing challenges. | Neuro Oncol | 2024 |
| 36843390 | DNA methylation-based classification of glioneuronal tumours synergises with histology and radiology to refine accurate molecular stratification. | | 2023 |
| 36375115 | Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade Glioma. | J Clin Oncol | 2023 |
| 36239316 | A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes. | Neuro-Oncology | 2023 |
| 35562551 | Visual outcomes and predictors in optic pathway glioma: a single centre study. | Eye | 2023 |
| 38022892 | A novel diagnostic method for a rare fungus: FcMBL facilitates identification in an immunocompromised neonate. | | 2023 |
| 37733309 | Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations. | N Engl J Med | 2023 |
| 37643378 | Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade Glioma. | J Clin Oncol | 2023 |
| 37091147 | Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks. | Front Oncol | 2023 |
| 36884302 | Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosis. | | 2023 |
| 37075810 | LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients. | Neuro Oncol | 2023 |
| 36808285 | Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908. | Neuro Oncol | 2023 |
| 36790496 | Atypical teratoid rhabdoid tumours (ATRTs)-a 21-year institutional experience. | | 2023 |
| 35159015 | A 40-Year Cohort Study of Evolving Hypothalamic Dysfunction in Infants and Young Children (<3 years) with Optic Pathway Gliomas. | Cancers | 2022 |
| 35814457 | Neurological Symptom Improvement After Re-Irradiation in Patients With Diffuse Intrinsic Pontine Glioma: A Retrospective Analysis of the SIOP-E-HGG/DIPG Project. | Front Oncol | 2022 |
| 35489353 | Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. | Lancet Oncol | 2022 |
| 36335782 | Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. | Eur J Cancer | 2022 |
| 35799614 | Multimorbidity patterns and risk of hospitalisation in children: A population cohort study of 3.6 million children in England, with illustrative examples from childhood cancer survivors. | Lancet Regional Health - Europe, The | 2022 |
| 35733513 | Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates. | Neurooncol Adv | 2022 |
| 35412366 | MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial. | Radiology | 2022 |
| 35788692 | MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. | Neuro Oncol | 2022 |
| 35536420 | Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [F]FDG: version 1.0. | European Journal of Nuclear Medicine and Molecular Imaging | 2022 |
| 35976451 | Convection-Enhanced Delivery in Children: Techniques and Applications. | Advances and technical standards in neurosurgery | 2022 |
| 34737188 | DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition. | Cancer Discovery | 2022 |
| 35178860 | Location, symptoms, and management of plexiform neurofibromas in 127 children with neurofibromatosis 1, attending the National Complex Neurofibromatosis 1 service, 2018-2019. | American Journal of Medical Genetics, Part A | 2022 |
| 34546642 | Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma. | Pediatr Blood Cancer | 2022 |
| 34595479 | Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors. | Neurooncol Adv | 2021 |
| 33542327 | Classification of paediatric brain tumours by diffusion weighted imaging and machine learning. | Scientific Reports | 2021 |
| 34169282 | Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients. | Neurooncol Adv | 2021 |
| 34168987 | Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors. | Front Oncol | 2021 |
| 33797808 | Identifying cellular signalling molecules in developmental disorders of the brain: Evidence from focal cortical dysplasia and tuberous sclerosis. | Neuropathol Appl Neurobiol | 2021 |
| 33532921 | Neurosurgical experience of managing optic pathway gliomas. | Child's Nervous System | 2021 |
| 33664107 | A Diagnostic Algorithm for Posterior Fossa Tumors in Children: A Validation Study. | AJNR Am J Neuroradiol | 2021 |
| 33977272 | MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study. | Neurooncol Adv | 2021 |
| 32705327 | Spectrum of neuroimaging findings post-proton beam therapy in a large pediatric cohort. | Child's Nervous System | 2021 |
| 33241451 | Surveillance imaging of grade 1 astrocytomas in children: can duration and frequency of follow-up imaging and the use of contrast agents be reduced? | Neuroradiology | 2021 |
| 32628746 | NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat. | Neuro-Oncology | 2021 |
| 33226200 | Parents' responses to prognostic disclosure at diagnosis of a child with a high-risk brain tumor: Analysis of clinician-parent interactions and implications for clinical practice. | Pediatric Blood and Cancer | 2021 |
| 33325069 | A case series of Diffuse Glioneuronal Tumours with Oligodendroglioma-like features and Nuclear Clusters (DGONC). | Neuropathol Appl Neurobiol | 2021 |
| 34381018 | Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation. | Cell Death and Disease | 2021 |
| 31504816 | Molecular correlates of cerebellar mutism syndrome in medulloblastoma. | Neuro Oncol | 2020 |
| 31786093 | DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study. | Lancet Child Adolesc Health | 2020 |
| 32238360 | Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. | Cancer Discov | 2020 |
| 31924736 | Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial. | Clin Cancer Res | 2020 |
| 32451331 | A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in <i>BRAF</i>-Driven Pediatric Low-Grade Glioma Cells. | Mol Cancer Ther | 2020 |
| 33038669 | Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma. | NeuroImage: Clinical | 2020 |
| 32537177 | Systematic review: measurement properties of patient-reported outcome measures evaluated with childhood brain tumor survivors or other acquired brain injury. | Neuro-Oncology Practice | 2020 |
| 32859926 | Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity. | Nat Commun | 2020 |
| 33014399 | Regarding "Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma". | Neuro-Oncology Practice | 2020 |